Investigation of the chiral recognition ability of human carboxylesterase 1 using indomethacin esters

Chirality. 2020 Jan;32(1):73-80. doi: 10.1002/chir.23141. Epub 2019 Nov 6.

Abstract

Human carboxylesterase 1 (hCES1) is an enzyme that plays an important role in hydrolysis of pharmaceuticals in the human liver. In this study, elucidation of the chiral recognition ability of hCES1 was attempted using indomethacin esters in which various chiral alcohols were introduced. Indomethacin was condensed with various chiral alcohols to synthesize indomethacin esters. The synthesized esters were hydrolyzed with a human liver microsome (HLM) solution and a human intestine microsome (HIM) solution. High hydrolytic rate and high stereoselectivity were confirmed in the hydrolysis reaction in the HLM solution but not in the HIM solution, and these indomethacin esters were thought to be hydrolyzed by hCES1. Next, these indomethacin esters were hydrolyzed in recombinant hCES1 solution and the hydrolysis rates of the esters were calculated. The stereoselectivity confirmed in HLM solution was also confirmed in the hCES1 solution. In the hydrolysis reaction of esters in which a phenyl group is bonded next to the ester, the Vmax value of the (R) form was 10 times larger than that of the (S) form.

Keywords: carboxylesterase; chiral recognition; ester prodrug; indomethacin; substrate specificity1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carboxylic Ester Hydrolases / chemistry
  • Carboxylic Ester Hydrolases / metabolism*
  • Esters / chemistry
  • Humans
  • Hydrolysis
  • Inactivation, Metabolic
  • Indomethacin / chemistry*
  • Indomethacin / metabolism
  • Intestines / drug effects
  • Male
  • Microsomes, Liver / metabolism
  • Middle Aged
  • Stereoisomerism

Substances

  • Esters
  • Carboxylic Ester Hydrolases
  • CES1 protein, human
  • Indomethacin